Mitochondrial-Targeted Multifunctional Platinum-Based Nano “Terminal-Sensitive Projectile” for Enhanced Cancer Chemotherapy Efficacy
Authors:
- 25 February 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (9) , 8711-8726
Abstract
Platinum-based anticancer drugs exert their effects by forming adducts within nuclear DNA (nDNA), inhibiting transcription and inducing apoptosis in cancer cells. However, tumor cells have evolved mechanisms to resist these drugs. Given mitochondria's role in cancer and their lack of nucleotide excision repair (NER), targeting mitochondrial DNA (mtDNA) offers a strategy. Herein, a platinum-based terminal-sensitive projectile (TSB) which comprises a heterofunctional tetravalent platinum prodrug as the primary warhead, complemented by a guidance system incorporating triphenylphosphine (TPP) and a secondary warhead, FFa (Fenofibric acid) was developed. TSB was then encapsulated within IR780 coupling DSPE-PEG2K for enhanced delivery (NTSB). This design allows the TSB to be precisely targeted into intertumoral mitochondria as its targeting terminal, releasing free oxaliplatin (OXA) and FFa upon reaching its terminal destination. The accumulation of OXA leads to cross-linking with mtDNA, causing mitochondrial dysfunction, while FFa disrupts the electron transport chain (ETC), impairing oxidative phosphorylation (OXPHOS). Furthermore, under near-infrared (NIR) irradiation, the IR780 component generates a phototherapeutic thermal effect and reactive oxygen species (ROS), which deplete intracellular glutathione (GSH) levels and facilitate Pt cross-linking with mtDNA. Both in vitro and in vivo studies have demonstrated that this comprehensive approach significantly enhances the sensitivity of tumor cells to platinum-based chemotherapeutic drugs.Keywords
Funding Information
- Graduate Research and Innovation Projects of Jiangsu Province (KYCX23-2192)
- Science and Technology Foundation of Shenzhen City (JCYJ20240813103605008)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515011550)
- Shanghai Municipal Health Commission (20214Y0457)
- National Natural Science Foundation of China (52003211, 52073145)
- Natural Science Foundation of Shandong Province (ZR2024ME084)
- Jiangsu Key Discipline Construction Fund (035062024001-2)
This publication has 64 references indexed in Scilit:
- Tyrosinase‐Woven Melanin Nets for Melanoma Therapy through Targeted Mitochondrial Tethering and Enhanced Photothermal TreatmentAdvanced Materials, 2024
- Bioorthogonal Guided Activation of cGAS‐STING by AIE Photosensitizer Nanoparticles for Targeted Tumor Therapy and ImagingAdvanced Materials, 2023
- In Situ Vaccination with Mitochondria‐Targeting Immunogenic Death Inducer Elicits CD8+ T Cell‐Dependent Antitumor Immunity to Boost Tumor ImmunotherapyAdvanced Science, 2023
- Stimuli‐Responsive Metal Complexes for Biomedical ApplicationsAngewandte Chemie International Edition, 2022
- Photo‐Reduction with NIR Light of Nucleus‐Targeting Pt IV Nanoparticles for Combined Tumor‐Targeted Chemotherapy and Photodynamic ImmunotherapyAngewandte Chemie International Edition, 2022
- Mito‐Bomb: Targeting Mitochondria for Cancer TherapyAdvanced Materials, 2021
- Sequential PDT and PTT Using Dual‐Modal Single‐Walled Carbon Nanohorns Synergistically Promote Systemic Immune Responses against Tumor Metastasis and RelapseAdvanced Science, 2020
- Sterically Shielded Heptamethine Cyanine Dyes for Bioconjugation and High Performance Near‐Infrared Fluorescence ImagingAngewandte Chemie International Edition, 2020
- Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced NephrotoxicityAngewandte Chemie International Edition, 2019
- Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion‐Targeted Platinum(II) ComplexAngewandte Chemie International Edition, 2019